首页 > 最新文献

Archives of Iranian Medicine最新文献

英文 中文
Bilateral Mydriasis in a Post-parotidectomy Patient: A Case Report. 腮腺切除术后双侧瞳孔肿大1例。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-01 DOI: 10.34172/aim.34254
Ahmad Daneshi, Saleh Mohebbi, Milad Shemshadi, Hadi Ghanbari

Anticholinergic agents, such as atropine and glycopyrrolate, are commonly utilized during anesthesia for their effects on secretion reduction and vagal activity. However, substantial dosages can induce mydriasis, which poses diagnostic challenges, particularly in head and neck surgeries. Despite their clinical relevance, limited studies explore these effects. A 35-year-old female presented with a left parotid mass and scheduled for a left superficial parotidectomy. Preoperatively, the patient exhibited normal ocular and neurological function. Postoperatively, fine bilateral ptosis, predominantly on the left side, and bilateral unresponsive mydriasis were noted. Anticholinergic-induced pupillary changes may mimic neurological pathology, underscoring the necessity for meticulous postoperative evaluation and awareness among clinicians.

抗胆碱能药物,如阿托品和甘罗酸酯,通常在麻醉期间使用,因为它们对分泌减少和迷走神经活动有影响。然而,大量的剂量可引起瞳孔肿大,这给诊断带来了挑战,特别是在头颈部手术中。尽管它们具有临床意义,但探索这些影响的研究有限。一位35岁的女性,因左侧腮腺肿块,计划行左侧腮腺浅表性切除术。术前,患者的眼和神经功能正常。术后双侧轻度上睑下垂,以左侧为主,双侧无反应性睑下垂。抗胆碱能引起的瞳孔变化可能模仿神经病理学,强调了临床医生对术后细致评估和意识的必要性。
{"title":"Bilateral Mydriasis in a Post-parotidectomy Patient: A Case Report.","authors":"Ahmad Daneshi, Saleh Mohebbi, Milad Shemshadi, Hadi Ghanbari","doi":"10.34172/aim.34254","DOIUrl":"10.34172/aim.34254","url":null,"abstract":"<p><p>Anticholinergic agents, such as atropine and glycopyrrolate, are commonly utilized during anesthesia for their effects on secretion reduction and vagal activity. However, substantial dosages can induce mydriasis, which poses diagnostic challenges, particularly in head and neck surgeries. Despite their clinical relevance, limited studies explore these effects. A 35-year-old female presented with a left parotid mass and scheduled for a left superficial parotidectomy. Preoperatively, the patient exhibited normal ocular and neurological function. Postoperatively, fine bilateral ptosis, predominantly on the left side, and bilateral unresponsive mydriasis were noted. Anticholinergic-induced pupillary changes may mimic neurological pathology, underscoring the necessity for meticulous postoperative evaluation and awareness among clinicians.</p>","PeriodicalId":55469,"journal":{"name":"Archives of Iranian Medicine","volume":"28 6","pages":"367-369"},"PeriodicalIF":1.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12305409/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144769403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global Burden of Dental Caries and Oral Disorders: A 31-Year Comparative Analysis of Trends in Iran, North Africa and Middle East. 全球龋齿和口腔疾病负担:伊朗、北非和中东地区31年趋势比较分析
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-01 DOI: 10.34172/aim.33209
Saeed Asgary, Alireza Akbarzadeh Baghban, Fatemeh Mahmoudi Afsah

Background: The Global Burden of Disease (GBD) studies highlight oral health as a significant global concern, particularly in regions such as Iran, the Middle East and North Africa (MENA). This study synthesizes GBD data on the incidence, prevalence, and disability-adjusted life years (DALYs) associated with dental caries and oral disorders to inform targeted interventions aimed at alleviating their burden and improving outcomes in these regions.

Methods: This study employs estimation techniques to comprehensively assess the occurrence and impact of dental caries in deciduous and permanent teeth, along with oral disorders across Iran, MENA, and globally. Data were drawn from the GBD site. We analyzed incidence, prevalence, and DALYs, utilizing disability weights with joinpoint regression models to inform public health interventions.

Results: From 1990 to 2021, global and regional trends in dental caries and oral disorders were examined. Descriptive statistics illustrate significant regional disparities in incidence, prevalence, and DALYs. Globally, the incidence rate of caries in deciduous teeth decreased at an average annual percent change (AAPC) of -0.25% (95% CI: -0.30 to -0.20), while the MENA region and Iran showed AAPCs of -0.57% (-0.65 to -0.49) and -0.08% (-0.15 to -0.01), respectively. These trends highlight both progress and persistent disparities. The models reveal temporal changes in disease burden, with notable declines and fluctuations over time. These findings underscore persistent challenges in oral health, particularly in regions such as Iran and MENA, where socioeconomic conditions and healthcare access vary significantly.

Conclusion: This study underscores considerable regional variation in dental caries and oral disorders, emphasizing ongoing public health challenges. Demographic shifts and reduced sugar intake, influenced by sociopolitical factors like war, have significantly decreased the global burden of oral conditions since 1990. The findings underscore the urgency of integrating oral health into primary care systems, expanding subsidized fluoride programs in rural areas, and addressing socioeconomic barriers to dental access in MENA. Community-driven initiatives, such as school-based screenings and mobile dental clinics, should be prioritized in underserved regions.

背景:全球疾病负担(GBD)研究强调口腔健康是全球关注的重要问题,特别是在伊朗、中东和北非(MENA)等地区。本研究综合了GBD的发病率、患病率和与龋齿和口腔疾病相关的残疾调整生命年(DALYs)的数据,为有针对性的干预提供信息,旨在减轻这些地区的负担并改善结果。方法:本研究采用估算技术全面评估伊朗、中东和北非地区以及全球乳牙和恒牙龋齿以及口腔疾病的发生和影响。数据取自GBD现场。我们分析了发病率、患病率和DALYs,利用残疾权重和连接点回归模型为公共卫生干预提供信息。结果:从1990年到2021年,研究了全球和区域龋齿和口腔疾病的趋势。描述性统计表明,在发病率、流行率和DALYs方面存在显著的地区差异。在全球范围内,乳牙龋病发病率下降,年均百分比变化(AAPC)为-0.25% (95% CI: -0.30 ~ -0.20),而中东和北非地区和伊朗的AAPC分别为-0.57%(-0.65 ~ -0.49)和-0.08%(-0.15 ~ -0.01)。这些趋势既突出了进步,也突出了持续存在的差距。这些模型揭示了疾病负担的时间变化,随着时间的推移有显著的下降和波动。这些发现强调了口腔健康方面的持续挑战,特别是在伊朗和中东和北非等地区,这些地区的社会经济条件和医疗保健机会差异很大。结论:这项研究强调了龋病和口腔疾病的相当大的地区差异,强调了持续的公共卫生挑战。自1990年以来,受战争等社会政治因素的影响,人口结构的变化和糖摄入量的减少大大减轻了全球口腔疾病的负担。研究结果强调了将口腔健康纳入初级保健系统、扩大农村地区氟化物补贴计划以及解决中东和北非地区牙科就诊的社会经济障碍的紧迫性。社区驱动的举措,如学校筛查和流动牙科诊所,应优先在服务不足的地区开展。
{"title":"Global Burden of Dental Caries and Oral Disorders: A 31-Year Comparative Analysis of Trends in Iran, North Africa and Middle East.","authors":"Saeed Asgary, Alireza Akbarzadeh Baghban, Fatemeh Mahmoudi Afsah","doi":"10.34172/aim.33209","DOIUrl":"10.34172/aim.33209","url":null,"abstract":"<p><strong>Background: </strong>The Global Burden of Disease (GBD) studies highlight oral health as a significant global concern, particularly in regions such as Iran, the Middle East and North Africa (MENA). This study synthesizes GBD data on the incidence, prevalence, and disability-adjusted life years (DALYs) associated with dental caries and oral disorders to inform targeted interventions aimed at alleviating their burden and improving outcomes in these regions.</p><p><strong>Methods: </strong>This study employs estimation techniques to comprehensively assess the occurrence and impact of dental caries in deciduous and permanent teeth, along with oral disorders across Iran, MENA, and globally. Data were drawn from the GBD site. We analyzed incidence, prevalence, and DALYs, utilizing disability weights with joinpoint regression models to inform public health interventions.</p><p><strong>Results: </strong>From 1990 to 2021, global and regional trends in dental caries and oral disorders were examined. Descriptive statistics illustrate significant regional disparities in incidence, prevalence, and DALYs. Globally, the incidence rate of caries in deciduous teeth decreased at an average annual percent change (AAPC) of -0.25% (95% CI: -0.30 to -0.20), while the MENA region and Iran showed AAPCs of -0.57% (-0.65 to -0.49) and -0.08% (-0.15 to -0.01), respectively. These trends highlight both progress and persistent disparities. The models reveal temporal changes in disease burden, with notable declines and fluctuations over time. These findings underscore persistent challenges in oral health, particularly in regions such as Iran and MENA, where socioeconomic conditions and healthcare access vary significantly.</p><p><strong>Conclusion: </strong>This study underscores considerable regional variation in dental caries and oral disorders, emphasizing ongoing public health challenges. Demographic shifts and reduced sugar intake, influenced by sociopolitical factors like war, have significantly decreased the global burden of oral conditions since 1990. The findings underscore the urgency of integrating oral health into primary care systems, expanding subsidized fluoride programs in rural areas, and addressing socioeconomic barriers to dental access in MENA. Community-driven initiatives, such as school-based screenings and mobile dental clinics, should be prioritized in underserved regions.</p>","PeriodicalId":55469,"journal":{"name":"Archives of Iranian Medicine","volume":"28 6","pages":"324-333"},"PeriodicalIF":1.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12305416/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144769338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Illegal Abortion in Iran: Challenges, Consequences, Recommendations. 伊朗的非法堕胎:挑战、后果、建议。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-01 DOI: 10.34172/aim.34080
Habibollah Azarbakhsh, Mahdiyeh Rashedi
{"title":"Illegal Abortion in Iran: Challenges, Consequences, Recommendations.","authors":"Habibollah Azarbakhsh, Mahdiyeh Rashedi","doi":"10.34172/aim.34080","DOIUrl":"10.34172/aim.34080","url":null,"abstract":"","PeriodicalId":55469,"journal":{"name":"Archives of Iranian Medicine","volume":"28 6","pages":"372-373"},"PeriodicalIF":1.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12305420/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144769339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum Uric Acid Levels and Bone Mineral Density in Peri- and Postmenopausal Korean Women: A Cross-sectional Study on 3,566 Cases. 绝经前后韩国妇女血清尿酸水平和骨密度:3566例横断面研究
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-06-01 DOI: 10.34172/aim.34066
Ki-Bong Park, Minsu Han, Su Jin Choi, Gyung-Min Park, Young-Jee Jeon, Doo-Ho Lim

Background: Uric acid (UA) may influence bone health through its antioxidant and pro-oxidant properties. While previous studies have investigated the relationship between serum UA levels and bone mineral density (BMD), their findings have been conflicting. This study aimed to examine the impact of serum UA levels on BMD in peri- and postmenopausal Korean women.

Methods: We evaluated 3,566 women aged 50-80 years who voluntarily underwent laboratory tests and BMD measurements as part of a general health examination between March 2014 and March 2020. Participants were stratified into quartiles according to their serum UA levels. Univariate and multivariate analyses were performed to assess the association between serum UA levels and BMD.

Results: The mean age of the participants was 56.9±5.8 years. BMD at the lumbar spine and hip was significantly higher in women with elevated serum UA levels, showing a continuous increase across the quartiles. Furthermore, after adjusting for covariates, the mean total lumbar spine BMD increased from 0.892 g/cm² (95% CI: 0.884-0.900) in the lowest UA quartile to 0.918 g/cm² (95% CI: 0.909-0.927) in the highest quartile (P<0.001). Similarly, the adjusted total hip BMD was higher in the highest UA quartile at 0.847 g/cm² (95% CI: 0.840-0.854) compared with 0.828 g/cm² (95% CI: 0.821-0.834) in the lowest quartile (P=0.001).

Conclusion: Our results suggest that elevated serum UA levels are associated with higher BMD in peri- and postmenopausal Korean women, indicating a potential protective role in bone metabolism.

背景:尿酸(UA)可能通过其抗氧化和促氧化特性影响骨骼健康。虽然之前的研究已经调查了血清尿酸水平和骨密度(BMD)之间的关系,但他们的发现是相互矛盾的。本研究旨在探讨血清尿酸水平对围绝经期和绝经后韩国妇女骨密度的影响。方法:我们评估了3566名年龄在50-80岁之间的女性,她们在2014年3月至2020年3月期间自愿接受了实验室检查和骨密度测量,作为一般健康检查的一部分。根据受试者血清UA水平将其分为四分位数。单因素和多因素分析评估血清尿酸水平和骨密度之间的关系。结果:患者平均年龄56.9±5.8岁。在血清UA水平升高的女性中,腰椎和髋部的骨密度明显更高,在四分位数中显示出持续的增加。此外,在调整协变量后,平均腰椎总骨密度从最低UA四分位数的0.892 g/cm²(95% CI: 0.884-0.900)增加到最高四分位数的0.918 g/cm²(95% CI: 0.909-0.927) (PP=0.001)。结论:我们的研究结果表明,血清UA水平升高与绝经前后韩国女性较高的骨密度有关,表明其在骨代谢中具有潜在的保护作用。
{"title":"Serum Uric Acid Levels and Bone Mineral Density in Peri- and Postmenopausal Korean Women: A Cross-sectional Study on 3,566 Cases.","authors":"Ki-Bong Park, Minsu Han, Su Jin Choi, Gyung-Min Park, Young-Jee Jeon, Doo-Ho Lim","doi":"10.34172/aim.34066","DOIUrl":"10.34172/aim.34066","url":null,"abstract":"<p><strong>Background: </strong>Uric acid (UA) may influence bone health through its antioxidant and pro-oxidant properties. While previous studies have investigated the relationship between serum UA levels and bone mineral density (BMD), their findings have been conflicting. This study aimed to examine the impact of serum UA levels on BMD in peri- and postmenopausal Korean women.</p><p><strong>Methods: </strong>We evaluated 3,566 women aged 50-80 years who voluntarily underwent laboratory tests and BMD measurements as part of a general health examination between March 2014 and March 2020. Participants were stratified into quartiles according to their serum UA levels. Univariate and multivariate analyses were performed to assess the association between serum UA levels and BMD.</p><p><strong>Results: </strong>The mean age of the participants was 56.9±5.8 years. BMD at the lumbar spine and hip was significantly higher in women with elevated serum UA levels, showing a continuous increase across the quartiles. Furthermore, after adjusting for covariates, the mean total lumbar spine BMD increased from 0.892 g/cm² (95% CI: 0.884-0.900) in the lowest UA quartile to 0.918 g/cm² (95% CI: 0.909-0.927) in the highest quartile (<i>P</i><0.001). Similarly, the adjusted total hip BMD was higher in the highest UA quartile at 0.847 g/cm² (95% CI: 0.840-0.854) compared with 0.828 g/cm² (95% CI: 0.821-0.834) in the lowest quartile (<i>P</i>=0.001).</p><p><strong>Conclusion: </strong>Our results suggest that elevated serum UA levels are associated with higher BMD in peri- and postmenopausal Korean women, indicating a potential protective role in bone metabolism.</p>","PeriodicalId":55469,"journal":{"name":"Archives of Iranian Medicine","volume":"28 6","pages":"341-346"},"PeriodicalIF":1.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12305421/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144769340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Burden of Breast Cancer Attributable to a Diet High in Red Meat at Global, Regional, and National Levels: An Analysis of the Global Burden of Disease Study 2021. 在全球、地区和国家层面上,高红肉饮食导致的乳腺癌负担:2021年全球疾病负担研究分析
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-05-01 DOI: 10.34172/aim.34079
Fang Zhou, Jincheng Tang, Renyi Yang, Puhua Zeng, Jianxiong Cao

Background: Dietary factors are a key risk for breast cancer. This study examines the global burden of breast cancer attributed to a high red meat diet from 1990 to 2021.

Methods: Using Global Burden of Disease Study (GBD) 2021 data, deaths and disability-adjusted life-years (DALYs) were analyzed globally, regionally, and nationally. Trends were assessed through estimated annual percentage changes (EAPCs) in age-standardized mortality (ASMR) and DALY (ASDR) rates. A decomposition analysis quantified the contributions of population growth, aging, and epidemiological changes. The relationship between sociodemographic index (SDI) and burden was examined using Spearman rank test. Health inequalities were assessed using the Slope Index of Inequality for absolute inequality and the Concentration Index for relative inequality.

Results: By 2021, breast cancer deaths and DALYs linked to high red meat intake had increased significantly compared to 1990, despite a decline in ASMR [EAPC: -0.77 (95% CI -0.82 to -0.72)] and ASDR [EAPC: -0.65 (95% CI -0.70 to -0.60)]. These trends were driven by population growth and aging, with regional variability in the pace of demographic transitions. North Africa and the Middle East experienced the largest rise in ASMR [EAPC: 2.03 (95% CI 1.79 to 2.26)], while Pacific Island nations had the highest ASMR and ASDR. High-SDI regions had the highest ASMR [1.14 per 100000 (95% UI -0.01‒2.43)] and ASDR [33.07 per 100000 (95% UI -0.02‒69.90)], with a positive SDI-burden correlation in low- and middle-SDI regions (P<0.05), but a negative correlation in high-SDI regions (P<0.05). From 1990 to 2021, absolute inequality [35.79 (95% CI 29.13‒42.46) vs. 4.99 (95% CI -1.59-11.56)] and relative inequality [0.18 (95% CI 0.16‒0.21) vs. 0.02 (95% CI -0.01‒0.05)] decreased.

Conclusion: Although ASMR and ASDR have declined, the absolute burden of breast cancer due to high red meat intake remains significant, particularly in aging and rapidly urbanizing populations. Policy interventions should include taxation on red meat, restrictions on processed meat, and public health campaigns promoting dietary modifications. Targeted screening programs in high-risk regions, especially for middle-aged and elderly populations, are critical for mitigating the future disease burden.

背景:饮食因素是乳腺癌的关键风险因素。这项研究调查了1990年至2021年期间高红肉饮食导致的全球乳腺癌负担。方法:使用全球疾病负担研究(GBD) 2021数据,对全球、地区和国家的死亡和残疾调整生命年(DALYs)进行分析。通过估计年龄标准化死亡率(ASMR)和DALY (ASDR)率的年百分比变化(EAPCs)来评估趋势。分解分析量化了人口增长、老龄化和流行病学变化的贡献。采用Spearman秩检验检验社会人口学指数(SDI)与负担的关系。使用绝对不平等的不平等斜率指数和相对不平等的浓度指数来评估健康不平等。结果:到2021年,尽管ASMR [EAPC: -0.77 (95% CI: -0.82至-0.72)]和ASDR [EAPC: -0.65 (95% CI: -0.70至-0.60)]下降,但与1990年相比,与高红肉摄入相关的乳腺癌死亡率和DALYs显著增加。这些趋势是由人口增长和老龄化推动的,人口转型的速度存在区域差异。北非和中东经历了最大的ASMR上升[EAPC: 2.03 (95% CI 1.79至2.26)],而太平洋岛国的ASMR和ASDR最高。高sdi地区的ASMR [1.14 / 100000 (95% UI -0.01 - 2.43)]和ASDR [33.07 / 100000 (95% UI -0.02 - 69.90)]最高,低sdi和中等sdi地区的sdi -负担呈正相关(pp结论:尽管ASMR和ASDR已经下降,但高红肉摄入导致的乳腺癌绝对负担仍然显著,特别是在老龄化和快速城市化的人群中。政策干预应包括对红肉征税,限制加工肉类,以及促进饮食调整的公共卫生运动。在高风险地区,特别是针对中老年人群的有针对性的筛查计划,对于减轻未来的疾病负担至关重要。
{"title":"Burden of Breast Cancer Attributable to a Diet High in Red Meat at Global, Regional, and National Levels: An Analysis of the Global Burden of Disease Study 2021.","authors":"Fang Zhou, Jincheng Tang, Renyi Yang, Puhua Zeng, Jianxiong Cao","doi":"10.34172/aim.34079","DOIUrl":"10.34172/aim.34079","url":null,"abstract":"<p><strong>Background: </strong>Dietary factors are a key risk for breast cancer. This study examines the global burden of breast cancer attributed to a high red meat diet from 1990 to 2021.</p><p><strong>Methods: </strong>Using Global Burden of Disease Study (GBD) 2021 data, deaths and disability-adjusted life-years (DALYs) were analyzed globally, regionally, and nationally. Trends were assessed through estimated annual percentage changes (EAPCs) in age-standardized mortality (ASMR) and DALY (ASDR) rates. A decomposition analysis quantified the contributions of population growth, aging, and epidemiological changes. The relationship between sociodemographic index (SDI) and burden was examined using Spearman rank test. Health inequalities were assessed using the Slope Index of Inequality for absolute inequality and the Concentration Index for relative inequality.</p><p><strong>Results: </strong>By 2021, breast cancer deaths and DALYs linked to high red meat intake had increased significantly compared to 1990, despite a decline in ASMR [EAPC: -0.77 (95% CI -0.82 to -0.72)] and ASDR [EAPC: -0.65 (95% CI -0.70 to -0.60)]. These trends were driven by population growth and aging, with regional variability in the pace of demographic transitions. North Africa and the Middle East experienced the largest rise in ASMR [EAPC: 2.03 (95% CI 1.79 to 2.26)], while Pacific Island nations had the highest ASMR and ASDR. High-SDI regions had the highest ASMR [1.14 per 100000 (95% UI -0.01‒2.43)] and ASDR [33.07 per 100000 (95% UI -0.02‒69.90)], with a positive SDI-burden correlation in low- and middle-SDI regions (<i>P</i><0.05), but a negative correlation in high-SDI regions (<i>P</i><0.05). From 1990 to 2021, absolute inequality [35.79 (95% CI 29.13‒42.46) vs. 4.99 (95% CI -1.59-11.56)] and relative inequality [0.18 (95% CI 0.16‒0.21) vs. 0.02 (95% CI -0.01‒0.05)] decreased.</p><p><strong>Conclusion: </strong>Although ASMR and ASDR have declined, the absolute burden of breast cancer due to high red meat intake remains significant, particularly in aging and rapidly urbanizing populations. Policy interventions should include taxation on red meat, restrictions on processed meat, and public health campaigns promoting dietary modifications. Targeted screening programs in high-risk regions, especially for middle-aged and elderly populations, are critical for mitigating the future disease burden.</p>","PeriodicalId":55469,"journal":{"name":"Archives of Iranian Medicine","volume":"28 5","pages":"275-285"},"PeriodicalIF":1.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12305419/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144769392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Medical Associations in Iran with Europe and America. 伊朗医学协会与欧美的比较。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-05-01 DOI: 10.34172/aim.20125
Nasim Hatefimoadab, Pegah Matourypour, Noredin Mohamadi, Alireza Nikbakht Nasrabadi, Hamid Peirovi, Shahrzad Ghiyasvandian, Hamid Reza Eshraghi, Mohammad Ali Cheraghi, Ali Mohammad Mosadegh Rad, Masoud Fallahi Khoshknab

Background: A comparative study of the structure, characteristics, background, and functions of scientific associations of medical sciences in Iran with other leading countries in the field of medical sciences can serve as a way forward for the future planning of these associations. This research was conducted to compare the status of medical associations in Iran and European and American countries.

Methods: This is a descriptive-comparative study. After selecting scientific associations in Iran, Europe, and America, data were collected by triangulation. To validate the study's findings, the results of the comparisons were discussed in a meeting attended by ten medical association's representative.

Results: The structure of medical associations in Iran reveals significant differences compared to their counterparts in European and American countries. The primary mission of medical associations in Iran is focused on professional development; however, their roles in policymaking are not clearly defined. All analyzed associations, whether in Iran, Europe, or the US, operate as private, non-profit entities. In terms of performance, Iranian medical associations display the highest activity levels in education (66.6%), social engagement (70%), and research (76.6%). However, they lack engagement in advisory services and advocacy-related activities. Conversely, medical associations in the US are active across all these domains, playing a significant role in healthcare.

Conclusion: The results of the present study show that in Iran, most scientific associations are limited to activities in the field of education and research, while in European and American countries, they play a role in policy making and as advocates for their members.

背景:将伊朗医学科学协会的结构、特点、背景和职能与医学科学领域的其他主要国家进行比较研究,可以作为这些协会未来规划的前进方向。这项研究是为了比较伊朗和欧美国家医学协会的状况。方法:采用描述性比较研究。在选取伊朗、欧洲和美国的科学协会后,采用三角测量法收集数据。为了验证这项研究的发现,十个医学协会的代表参加了一次会议,讨论了比较的结果。结果:伊朗医学协会的结构与欧美国家相比有显著差异。伊朗医学协会的主要任务是注重专业发展;然而,他们在政策制定中的作用并没有明确界定。所有被分析的协会,无论是在伊朗、欧洲还是美国,都是作为私人、非营利实体运作的。就业绩而言,伊朗医学协会在教育(66.6%)、社会参与(70%)和研究(76.6%)方面的活动水平最高。然而,他们缺乏参与咨询服务和宣传活动。相反,美国的医学协会在所有这些领域都很活跃,在医疗保健领域发挥着重要作用。结论:本研究结果表明,在伊朗,大多数科学协会仅限于教育和研究领域的活动,而在欧洲和美国国家,它们在政策制定中发挥作用,并作为其成员的倡导者。
{"title":"Comparison of Medical Associations in Iran with Europe and America.","authors":"Nasim Hatefimoadab, Pegah Matourypour, Noredin Mohamadi, Alireza Nikbakht Nasrabadi, Hamid Peirovi, Shahrzad Ghiyasvandian, Hamid Reza Eshraghi, Mohammad Ali Cheraghi, Ali Mohammad Mosadegh Rad, Masoud Fallahi Khoshknab","doi":"10.34172/aim.20125","DOIUrl":"10.34172/aim.20125","url":null,"abstract":"<p><strong>Background: </strong>A comparative study of the structure, characteristics, background, and functions of scientific associations of medical sciences in Iran with other leading countries in the field of medical sciences can serve as a way forward for the future planning of these associations. This research was conducted to compare the status of medical associations in Iran and European and American countries.</p><p><strong>Methods: </strong>This is a descriptive-comparative study. After selecting scientific associations in Iran, Europe, and America, data were collected by triangulation. To validate the study's findings, the results of the comparisons were discussed in a meeting attended by ten medical association's representative.</p><p><strong>Results: </strong>The structure of medical associations in Iran reveals significant differences compared to their counterparts in European and American countries. The primary mission of medical associations in Iran is focused on professional development; however, their roles in policymaking are not clearly defined. All analyzed associations, whether in Iran, Europe, or the US, operate as private, non-profit entities. In terms of performance, Iranian medical associations display the highest activity levels in education (66.6%), social engagement (70%), and research (76.6%). However, they lack engagement in advisory services and advocacy-related activities. Conversely, medical associations in the US are active across all these domains, playing a significant role in healthcare.</p><p><strong>Conclusion: </strong>The results of the present study show that in Iran, most scientific associations are limited to activities in the field of education and research, while in European and American countries, they play a role in policy making and as advocates for their members.</p>","PeriodicalId":55469,"journal":{"name":"Archives of Iranian Medicine","volume":"28 5","pages":"296-302"},"PeriodicalIF":1.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12305405/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144769395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy Of N-Acetyl-Cysteine as Adjuvant Therapy for Diabetic Foot Osteomyelitis: An Open-Label Randomized Controlled Trial. n-乙酰半胱氨酸辅助治疗糖尿病足骨髓炎的疗效:一项开放标签随机对照试验。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-05-01 DOI: 10.34172/aim.33355
Laya Hooshmand Gharabagh, Mehdi Heydaroghli, Ayda Esmaeili

Background: Biofilm formation by bacteria on the lower limb arises from reduced peripheral arterial blood flow, which can lead to the failure of antibiotic therapy or require longer duration of intravenous antibiotic therapy in diabetic foot infection-associated osteomyelitis. N-acetyl cysteine (NAC), an agent known to prevent and treat biofilm-related infections, was used as a novel strategies beside antibiotic therapy in osteomyelitis of diabetic foot with the aim of accelerating the response to antibiotic therapy regimen.

Methods: To assess the synergistic effect of NAC with antibiotic therapy, patients with diabetic foot osteomyelitis (DFO) (grade III or IV Wagner) were randomly assigned to either NAC 600 mg effervescent tablet twice daily for 2 weeks or the control group. Clinical and laboratory data, including white blood cell with differentiation and inflammatory factors (ESR and CRP) were measured at baseline (time 0), after one week and after three weeks of initiating the intervention.

Results: Fifty-three eligible patients completed the study. All evaluated infectious-related laboratory parameters showed significant reductions in the NAC group compared to control (P<0.05), except for lymphocyte proportion and NLR (P; 0.11 and 0.84, respectively). The drop rate of ESR and CRP were accelerated by NAC compared to the control group (-49.44±6.04 vs -7.17±3.99; -44.43±4.21 vs -14.02±4.05, respectively, P<0.05).

Conclusion: In order to accelerate antibiotic responses and the trend of reduction in infectious inflammatory markers during the therapy, oral NAC 600 mg twice daily may be considered in the treatment protocol of patients with DFO.

背景:糖尿病足感染相关性骨髓炎患者下肢细菌形成生物膜的原因是外周动脉血流减少,这可能导致抗生素治疗失败或需要更长时间的静脉抗生素治疗。n -乙酰半胱氨酸(NAC)是一种已知的预防和治疗生物膜相关感染的药物,作为抗生素治疗糖尿病足骨髓炎的新策略,旨在加速对抗生素治疗方案的反应。方法:为了评估NAC与抗生素治疗的协同作用,将糖尿病足骨髓炎(III级或IV级Wagner)患者随机分配至NAC 600 mg泡腾片组,每日2次,连续2周。临床和实验室数据,包括白细胞分化和炎症因子(ESR和CRP)在基线(时间0),一周后和三周后开始干预。结果:53名符合条件的患者完成了研究。与对照组相比,所有评估的感染相关实验室参数均显示NAC组显著降低(ppp)。结论:为了在治疗过程中加速抗生素反应和降低感染炎症标志物的趋势,可考虑在DFO患者的治疗方案中口服NAC 600 mg,每日2次。
{"title":"Efficacy Of N-Acetyl-Cysteine as Adjuvant Therapy for Diabetic Foot Osteomyelitis: An Open-Label Randomized Controlled Trial.","authors":"Laya Hooshmand Gharabagh, Mehdi Heydaroghli, Ayda Esmaeili","doi":"10.34172/aim.33355","DOIUrl":"10.34172/aim.33355","url":null,"abstract":"<p><strong>Background: </strong>Biofilm formation by bacteria on the lower limb arises from reduced peripheral arterial blood flow, which can lead to the failure of antibiotic therapy or require longer duration of intravenous antibiotic therapy in diabetic foot infection-associated osteomyelitis. N-acetyl cysteine (NAC), an agent known to prevent and treat biofilm-related infections, was used as a novel strategies beside antibiotic therapy in osteomyelitis of diabetic foot with the aim of accelerating the response to antibiotic therapy regimen.</p><p><strong>Methods: </strong>To assess the synergistic effect of NAC with antibiotic therapy, patients with diabetic foot osteomyelitis (DFO) (grade III or IV Wagner) were randomly assigned to either NAC 600 mg effervescent tablet twice daily for 2 weeks or the control group. Clinical and laboratory data, including white blood cell with differentiation and inflammatory factors (ESR and CRP) were measured at baseline (time 0), after one week and after three weeks of initiating the intervention.</p><p><strong>Results: </strong>Fifty-three eligible patients completed the study. All evaluated infectious-related laboratory parameters showed significant reductions in the NAC group compared to control (<i>P</i><0.05), except for lymphocyte proportion and NLR (P; 0.11 and 0.84, respectively). The drop rate of ESR and CRP were accelerated by NAC compared to the control group (-49.44±6.04 vs -7.17±3.99; -44.43±4.21 vs -14.02±4.05, respectively, <i>P</i><0.05).</p><p><strong>Conclusion: </strong>In order to accelerate antibiotic responses and the trend of reduction in infectious inflammatory markers during the therapy, oral NAC 600 mg twice daily may be considered in the treatment protocol of patients with DFO.</p>","PeriodicalId":55469,"journal":{"name":"Archives of Iranian Medicine","volume":"28 5","pages":"257-263"},"PeriodicalIF":1.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12305412/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144769397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Typhus Disease in Iran during the Qajar Period (1796 to 1925 AD); a Brief Historical Review. 校正:卡扎尔王朝时期(公元1796年至1925年)伊朗斑疹伤寒;简要历史回顾。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-05-01 DOI: 10.34172/aim.34549
Seyyed Alireza Golshani, Ghobad Mansourbakht
{"title":"Correction: Typhus Disease in Iran during the Qajar Period (1796 to 1925 AD); a Brief Historical Review.","authors":"Seyyed Alireza Golshani, Ghobad Mansourbakht","doi":"10.34172/aim.34549","DOIUrl":"10.34172/aim.34549","url":null,"abstract":"","PeriodicalId":55469,"journal":{"name":"Archives of Iranian Medicine","volume":"28 5","pages":"323"},"PeriodicalIF":1.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12305413/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144769396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Analysis of Clinical Characteristics in Multi-organ and Single-organ Involvement of IgG4-Related Disease: A Single-center Retrospective Study. igg4相关疾病多器官与单器官受累的临床特征比较分析:单中心回顾性研究
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-05-01 DOI: 10.34172/aim.34027
Dong-Ge Han, Chun-Lin Ying, Zi-Ping Cai, Qiao-Yun Tong, Wei Liu

Background: Immunoglobulin G4-related disease (IgG4-RD) is a rare, chronic inflammatory condition characterized by fibrosis and tendency for multi-organ involvement. This study aims to analyze the clinical characteristics associated with multi-organ versus single-organ involvement in IgG4-RD, thereby enhancing clinicians' understanding of the differences between these two patient groups and ultimately improving patient prognosis.

Methods: We performed a retrospective analysis of clinical data from 82 patients diagnosed with IgG4-RD admitted to Yichang Central People's Hospital between January 2019 and December 2024.

Results: Among the 82 patients diagnosed with IgG4-RD, 47 patients (57.32%) exhibited involvement of multiple organs. The incidence of multi-organ involvement was significantly higher in male patients than female patients [63.49% vs. 36.84%, odds ratio (OR): 2.98, 95% confidence intervals (CI): 1.03-8.64, P<0.05]. The misdiagnosis rate in the multi-organ involvement group was significantly higher than that in the single-organ involvement group (29.79% vs. 8.57%, OR: 4.525, 95% CI: 1.19-17.26, P<0.05). In patients with involvement of the pancreas (72.50% vs. 42.86%, OR: 3.515, 95% CI: 1.39-8.86, P<0.05), or lymph nodes (83.72% vs. 28.21%, OR: 13.091, 95% CI: 4.50-38.11, P<0.05), the incidence of additional organ involvement was significantly higher than those with involvement of other organs. The eosinophil percentage [median difference (Hodges-Lehmann): 1.60%, 95% CI: 0.40-2.80, P<0.05], absolute eosinophil count [median difference (Hodges-Lehmann): 0.10×109/L , 95% CI: 0.30-0.16, P<0.05], serum immunoglobulin G (IgG) levels [median difference (Hodges-Lehmann): 4.10 g/L, 95% CI: 0.10-7.80, P<0.05], and erythrocyte sedimentation rate (ESR) [median difference (Hodges-Lehmann): 30.50 mm/h, 95% CI: 13.00-48.00, P<0.05] were significantly higher in the multi-organ involvement group compared to the single-organ involvement group. There was a positive correlation between the number of involved organs and ESR (r=0.404, 95% CI: 0.166-0.597, P=0.001), eosinophil percentage (r=0.287, 95% CI: 0.068-0.480, P=0.009), absolute eosinophil count (r=0.293, 95% CI: 0.075-0.485, P=0.007), serum IgG levels (r=0.370, 95% CI: 0.130-0.570, P=0.003), and serum IgG4 levels (r=0.370, 95% CI: 0.130-0.570, P=0.003).

Conclusion: The clinical features associated with multi-organ involvement in IgG4-RD are characterized by significant diversity and complexity. Clinicians must enhance their understanding of the characteristics associated with multi-organ involvement to more effectively improve patient prognosis.

背景:免疫球蛋白g4相关疾病(IgG4-RD)是一种罕见的慢性炎症性疾病,以纤维化和多器官累及为特征。本研究旨在分析IgG4-RD多器官受累与单器官受累的临床特征,从而提高临床医生对这两组患者差异的认识,最终改善患者预后。方法:回顾性分析2019年1月至2024年12月宜昌市中心人民医院收治的82例确诊为IgG4-RD患者的临床资料。结果:在82例确诊为IgG4-RD的患者中,47例(57.32%)表现为多脏器受累。男性患者多器官受累发生率明显高于女性患者[63.49% vs. 36.84%,优势比(OR): 2.98, 95%可信区间(CI): 1.03-8.64, PPPPP9/L, 95% CI: 0.30-0.16, PPPr=0.404, 95% CI: 0.166-0.597, P=0.001],嗜酸性粒细胞百分比(r=0.287, 95% CI: 0.068-0.480, P=0.009),嗜酸性粒细胞绝对计数(r=0.293, 95% CI: 0.075-0.485, P=0.007),血清IgG水平(r=0.370, 95% CI: 0.130-0.570, P=0.003),血清IgG4水平(r=0.370, 95% CI: 0.130-0.570, P=0.003),血清IgG4水平(r=0.370, 95% CI:0.130 - -0.570, P = 0.003)。结论:IgG4-RD多器官受累的临床特征具有显著的多样性和复杂性。临床医生必须加强对多器官受累特征的了解,以更有效地改善患者预后。
{"title":"Comparative Analysis of Clinical Characteristics in Multi-organ and Single-organ Involvement of IgG4-Related Disease: A Single-center Retrospective Study.","authors":"Dong-Ge Han, Chun-Lin Ying, Zi-Ping Cai, Qiao-Yun Tong, Wei Liu","doi":"10.34172/aim.34027","DOIUrl":"10.34172/aim.34027","url":null,"abstract":"<p><strong>Background: </strong>Immunoglobulin G4-related disease (IgG4-RD) is a rare, chronic inflammatory condition characterized by fibrosis and tendency for multi-organ involvement. This study aims to analyze the clinical characteristics associated with multi-organ versus single-organ involvement in IgG4-RD, thereby enhancing clinicians' understanding of the differences between these two patient groups and ultimately improving patient prognosis.</p><p><strong>Methods: </strong>We performed a retrospective analysis of clinical data from 82 patients diagnosed with IgG4-RD admitted to Yichang Central People's Hospital between January 2019 and December 2024.</p><p><strong>Results: </strong>Among the 82 patients diagnosed with IgG4-RD, 47 patients (57.32%) exhibited involvement of multiple organs. The incidence of multi-organ involvement was significantly higher in male patients than female patients [63.49% vs. 36.84%, odds ratio (OR): 2.98, 95% confidence intervals (CI): 1.03-8.64, <i>P</i><0.05]. The misdiagnosis rate in the multi-organ involvement group was significantly higher than that in the single-organ involvement group (29.79% vs. 8.57%, OR: 4.525, 95% CI: 1.19-17.26, <i>P</i><0.05). In patients with involvement of the pancreas (72.50% vs. 42.86%, OR: 3.515, 95% CI: 1.39-8.86, <i>P</i><0.05), or lymph nodes (83.72% vs. 28.21%, OR: 13.091, 95% CI: 4.50-38.11, <i>P</i><0.05), the incidence of additional organ involvement was significantly higher than those with involvement of other organs. The eosinophil percentage [median difference (Hodges-Lehmann): 1.60%, 95% CI: 0.40-2.80, <i>P</i><0.05], absolute eosinophil count [median difference (Hodges-Lehmann): 0.10×10<sup>9</sup>/L , 95% CI: 0.30-0.16, <i>P</i><0.05], serum immunoglobulin G (IgG) levels [median difference (Hodges-Lehmann): 4.10 g/L, 95% CI: 0.10-7.80, <i>P</i><0.05], and erythrocyte sedimentation rate (ESR) [median difference (Hodges-Lehmann): 30.50 mm/h, 95% CI: 13.00-48.00, <i>P</i><0.05] were significantly higher in the multi-organ involvement group compared to the single-organ involvement group. There was a positive correlation between the number of involved organs and ESR (<i>r</i>=0.404, 95% CI: 0.166-0.597, <i>P</i>=0.001), eosinophil percentage (<i>r</i>=0.287, 95% CI: 0.068-0.480, <i>P</i>=0.009), absolute eosinophil count (<i>r</i>=0.293, 95% CI: 0.075-0.485, <i>P</i>=0.007), serum IgG levels (<i>r</i>=0.370, 95% CI: 0.130-0.570, <i>P</i>=0.003), and serum IgG4 levels (<i>r</i>=0.370, 95% CI: 0.130-0.570, <i>P</i>=0.003).</p><p><strong>Conclusion: </strong>The clinical features associated with multi-organ involvement in IgG4-RD are characterized by significant diversity and complexity. Clinicians must enhance their understanding of the characteristics associated with multi-organ involvement to more effectively improve patient prognosis.</p>","PeriodicalId":55469,"journal":{"name":"Archives of Iranian Medicine","volume":"28 5","pages":"303-312"},"PeriodicalIF":1.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12305410/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144769394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synergistic Effect of miR-383 and Cisplatin on Inhibition of Growth, Proliferation, and Migration of Lung Cancer Cells. miR-383与顺铂协同抑制肺癌细胞生长、增殖和迁移的作用
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-05-01 DOI: 10.34172/aim.33450
Vagef Elyaszadeh, Maryam Tohidast, Seyed Samad Hosseini, Mohammad Amini, Parinaz Marami, Behzad Baradaran, Amir Ali Mokhtarzadeh, Asiyeh Jebelli

Background: Lung cancer (LC) is a common life-threatening malignancy in humans. Cisplatin has been widely used in the treatment of various types of cancer. miR-383 is dysregulated in multiple cancers, and participates in tumorigenic processes, including apoptosis, proliferation, metastasis, and drug resistance. This study aimed to investigate the synergistic effect of miR-383 and cisplatin in LC.

Methods: A549 cells were treated with cisplatin and miR-383 separately or in combination. Cell viability, apoptosis induction, stemness features, migratory capacity, and autophagy were measured by various methods. In addition, quantitative real-time PCR (qRT-PCR) was used to evaluate the expression levels of genes involved in apoptosis, stemness, and migration.

Results: The results demonstrated that miR-383 transfection in A549 cells increased their chemosensitivity to cisplatin, enhancing cisplatin-induced apoptosis (from 11.28% to 37.86%). This effect was mediated by regulating key genes such as Bcl-2 and Caspase-3 (P<0.0001). Moreover, the combination of miR-383 and cisplatin synergistically reduced cell migration and colony formation. It also downregulated metastatic and stemness-related genes, including MMP-2 and CD44, respectively (P<0.0001).

Conclusion: The findings indicate that the combination treatment of miR-383 and cisplatin suppressed cell proliferation, migration and colony formation while enhancing the sensitivity of A549 cells to chemotherapy compared to monotherapy. These results suggest that miR-383 combination therapy warrants further investigation as a potential strategy for LC treatment.

背景:肺癌(LC)是人类常见的危及生命的恶性肿瘤。顺铂已被广泛用于治疗各种类型的癌症。miR-383在多种癌症中表达异常,并参与致瘤过程,包括凋亡、增殖、转移和耐药。本研究旨在探讨miR-383与顺铂在LC中的协同作用。方法:顺铂和miR-383分别或联合作用于A549细胞。采用多种方法测定细胞活力、诱导凋亡、干性、迁移能力和自噬。此外,采用实时荧光定量PCR (qRT-PCR)技术评估细胞凋亡、干性和迁移相关基因的表达水平。结果:结果表明,转染miR-383后,A549细胞对顺铂的化学敏感性增加,顺铂诱导的细胞凋亡增强(从11.28%增加到37.86%)。这种作用是通过调节关键基因Bcl-2和Caspase-3 (PMMP-2和CD44)等介导的。结论:miR-383与顺铂联合治疗可抑制A549细胞的增殖、迁移和集落形成,同时与单药治疗相比,提高A549细胞对化疗的敏感性。这些结果表明,miR-383联合治疗作为LC治疗的潜在策略值得进一步研究。
{"title":"Synergistic Effect of miR-383 and Cisplatin on Inhibition of Growth, Proliferation, and Migration of Lung Cancer Cells.","authors":"Vagef Elyaszadeh, Maryam Tohidast, Seyed Samad Hosseini, Mohammad Amini, Parinaz Marami, Behzad Baradaran, Amir Ali Mokhtarzadeh, Asiyeh Jebelli","doi":"10.34172/aim.33450","DOIUrl":"10.34172/aim.33450","url":null,"abstract":"<p><strong>Background: </strong>Lung cancer (LC) is a common life-threatening malignancy in humans. Cisplatin has been widely used in the treatment of various types of cancer. miR-383 is dysregulated in multiple cancers, and participates in tumorigenic processes, including apoptosis, proliferation, metastasis, and drug resistance. This study aimed to investigate the synergistic effect of miR-383 and cisplatin in LC.</p><p><strong>Methods: </strong>A549 cells were treated with cisplatin and miR-383 separately or in combination. Cell viability, apoptosis induction, stemness features, migratory capacity, and autophagy were measured by various methods. In addition, quantitative real-time PCR (qRT-PCR) was used to evaluate the expression levels of genes involved in apoptosis, stemness, and migration.</p><p><strong>Results: </strong>The results demonstrated that miR-383 transfection in A549 cells increased their chemosensitivity to cisplatin, enhancing cisplatin-induced apoptosis (from 11.28% to 37.86%). This effect was mediated by regulating key genes such as <i>Bcl-2</i> and <i>Caspase-3</i> (<i>P</i><0.0001). Moreover, the combination of miR-383 and cisplatin synergistically reduced cell migration and colony formation. It also downregulated metastatic and stemness-related genes, including <i>MMP-2</i> and <i>CD44</i>, respectively (<i>P</i><0.0001).</p><p><strong>Conclusion: </strong>The findings indicate that the combination treatment of miR-383 and cisplatin suppressed cell proliferation, migration and colony formation while enhancing the sensitivity of A549 cells to chemotherapy compared to monotherapy. These results suggest that miR-383 combination therapy warrants further investigation as a potential strategy for LC treatment.</p>","PeriodicalId":55469,"journal":{"name":"Archives of Iranian Medicine","volume":"28 5","pages":"264-274"},"PeriodicalIF":1.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12305408/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144769399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Archives of Iranian Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1